Get the Stockscreener App
9.24
18.31%
1.43
After Hours:
9.61
0.37
+4.00%
Quantum Biopharma Ltd stock is traded at $9.24, with a volume of 824.99K.
It is up +18.31% in the last 24 hours and up +175.82% over the past month.
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
See More
Previous Close:
$7.81
Open:
$7.8
24h Volume:
824.99K
Relative Volume:
1.85
Market Cap:
$59.12M
Revenue:
-
Net Income/Loss:
$-26.96M
P/E Ratio:
-1.0613
EPS:
-8.7061
Net Cash Flow:
$-8.25M
1W Performance:
+35.68%
1M Performance:
+175.82%
6M Performance:
+60.42%
1Y Performance:
+51.23%
1-Day Range:
$7.2101
$9.30
1-Week Range:
$6.07
$9.30
52-Week Range:
$2.07
$19.12
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Compare QNTM vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
9.24 | 49.97M | 0 | -26.96M | -8.25M | -8.7061 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Quantum Biopharma Ltd Stock (QNTM) Latest News
QNTM Should I Buy - Intellectia AI
Quantum BioPharma Reaches Halfway Point in Patient Enrollment in Imaging Study With MGH - Moomoo
Quantum BioPharma (QNTM) Reports Midpoint Enrollment Milestone in MS Imaging Study - NewMediaWire
Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital - Sahm
symbol__ Stock Quote Price and Forecast - CNN
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Midpoint Enrollment Milestone in MS Imaging Study - TipRanks
Quantum BioPharma (QNTM) Achieves Key Enrollment Milestone in MS Study - GuruFocus
Quantum BioPharma Shares Climb as Multiple Sclerosis Imaging Study Advances (QNTM) - Yahoo Finance
Quantum BioPharma reaches midpoint in MGH MS imaging study - grafa.com
Quantum BioPharma stock surges on MS imaging study progress - Investing.com
Quantum BioPharma stock surges on MS imaging study progress By Investing.com - Investing.com Canada
Quantum BioPharma Hits Midpoint in MGH Imaging Study as Lucid-MS Advances Toward Phase 2 - TipRanks
Quantum BioPharma (NASDAQ: QNTM) advances MS imaging and Lucid-MS plans - Stock Titan
Quantum BioPharma Ltd. Achieves Halfway Point in Collaborative MS Imaging Study with Massachusetts General Hospital - Quiver Quantitative
Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with ... - Enidnews.com
New MS PET scan in MGH-Quantum trial shows robust myelin damage signals - Stock Titan
QNTM Stock Price, Quote & Chart | QUANTUM BIOPHARMA-B SUB VOT (NASDAQ:QNTM) - ChartMill
Quantum BioPharma Boosts Liquidity and Advances Lucid-MS as U.S. Court Backs Market-Manipulation Suit - TipRanks
Number of shareholders of Quantum Biopharma Ltd. Subordinate Voting Shares Class B – MUN:0K91 - TradingView
Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026 - Stock Titan
Lucid-MS IND filing and longer cash runway at Quantum BioPharma (NASDAQ: QNTM) - Stock Titan
Quantum Biopharma Posts Higher Assets but Swings to Shareholders’ Deficit in Q1 2026 Filing - TipRanks
Quantum BioPharma Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[6-K] Quantum Biopharma Ltd. Current Report (Foreign Issuer) | QNTM SEC FilingForm 6-K - Stock Titan
Quantum BioPharma Provides Corporate Update - The Manila Times
Top Cannabis Stocks To Follow NowApril 27th - MarketBeat
Quantum Biopharma buys additional $1 million of Bitcoin, other cryptocurrencies - MSN
Quantum Biopharma bolsters Bitcoin treasury - MSN
Quantum BioPharma announces private placement - MSN
Cannabis Stocks To Watch NowApril 22nd - MarketBeat
Quantum BioPharma’s Unbuzzd Licensee Names New CEO to Drive U.S. Rollout of Clinically Backed Hangover Beverage - TipRanks
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant - The Manila Times
Unbuzzd’s new CEO to drive U.S. rollout for Quantum BioPharma (NASDAQ: QNTM) - Stock Titan
Quantum BioPharma Ltd. Announces Appointment of Richard Buzbuzian as CEO of Unbuzzd Wellness Inc. to Drive Commercialization of Innovative Beverage - Quiver Quantitative
Hangover remedy maker Unbuzzd picks CEO for rollout in Florida and Texas - Stock Titan
Promising Cannabis Stocks To Follow TodayApril 21st - MarketBeat
Quantum (QNTM) Stock: Momentum Behavior Insight (Slight Rise) 2026-04-20Shared Buy Zones - Cổng thông tin điện tử tỉnh Lào Cai
Press Releases about Royal Bank of Canada (Toronto Stock Exchange:RY) - FinancialContent
Value Recap: Should I invest in Quantum BioPharma Ltd before earnings2026 News Drivers & Technical Buy Zone Confirmation - baoquankhu1.vn
Operating expenses (excl. COGS) of Quantum Biopharma Ltd. Subordinate Voting Shares Class B – HAM:0K91 - TradingView — Track All Markets
Whats the fair value of Quantum BioPharma Ltd stockWeekly Gains Report & Risk Managed Investment Entry Signals - baoquankhu1.vn
Recap Report: Can Quantum BioPharma Ltd generate free cash flow2026 Historical Comparison & Stock Timing and Entry Methods - baoquankhu1.vn
Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements - ACCESS Newswire
Can Quantum (QNTM) Stock Beat Estimates | Price at $3.58, Down 10.05%Community Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Quantum Biopharma Ltd Stock (QNTM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.98%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):